Clinical Trials Logo

Neurocognitive clinical trials

View clinical trials related to Neurocognitive.

Filter by:
  • None
  • Page 1

NCT ID: NCT04829019 Recruiting - Neurocognitive Clinical Trials

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Start date: April 7, 2021
Phase: Phase 2
Study type: Interventional

This is a prospective, randomised, positive-controlled, study to assess the neurocognitive function of upfront Osimertinib compared to whole-brain irradiation (WBI) plus Osimertinib in EGFR-mutant (Ex 19Del and L858R) NSCLC patients with symptomatic brain metastases, as well as the efficacy and safety.

NCT ID: NCT03169881 Active, not recruiting - Neonatal Clinical Trials

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

Darbe
Start date: September 20, 2017
Phase: Phase 3
Study type: Interventional

Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo